XHH-11858-69567
4 vaccinations
1 coded response
40 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 631 / MO
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Registered in v-safe
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
-
2021-03-23
Dose 2 — Pfizer-BioNTech
- 2021-03-23
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-06-22
- 2021-09-21
-
2021-11-21
Dose 3 — Pfizer-BioNTech
- 2022-03-25
- 2022-05-22
-
2022-09-30
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-30
-
2022-10-01
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-12-30
-
2023-03-31
Survey response — 6 months, dose 4MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-03-31
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-23 | Pfizer-BioNTech | |
| 3 | 2021-11-21 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-31 | Unsuccessful |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release